Sort
48,018 grants matching “immunotherapy”
Enhancing cell therapy for brain tumors
$636,455Catherine Mary Bollard · Children'S Research Institute · U01 · FY2021 · CA
Reducing Cancer Transcriptional Heterogeneity through Regulation of Chromatin Structure
$636,330Vadim Backman · Northwestern University · R01 · FY2020 · CA
Multi-Antigen Vaccines for the Primary and Secondary Prevention of Bladder CancerTO POP: 9/15/2017 - 3/14/2019
$636,313Clinton Grubbs · University Of Alabama At Birmingham · N01 · FY2017 · CA
Multiscale Computational Models Guided By Emerging Cellular Dynamics Quantification For Predicting Optimum Immune Checkpoint And Targeted Therapy Schedules
$636,267Trachette Jackson · University Of Michigan At Ann Arbor · U01 · FY2022 · CA
Defining mechanisms of how immune checkpoint inhibitor-associated bacteria modulate tumor immunity in cancer
$636,222Marlies Meisel · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Ultrasensitive kinase biosensors for multiplex imaging of coordinated spatiotemporal signaling in cancer-immune interactions
$636,160Jin Zhang · University Of California, San Diego · R01 · FY2023 · CA
Integrated blood and radiomic subtyping to guide immunotherapy treatment selection and early response assessment in metastatic non-small cell lung cancer
$636,160Natalie Vokes · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Advancing treatment outcomes in malignant glioma by integrating immunotherapy and standard of care using genetically engineered mice that recapitulate molecular feature of human glioma
$635,966Alain Charest · Beth Israel Deaconess Medical Center · R01 · FY2022 · CA
A precision oncology approach to integrating of tumor microenvironment suppressive cell modulators to enhance antitumor immunity
$635,965Dung T Le · Johns Hopkins University · P01 · FY2024 · CA
Melanocyte PDL1 control of UVB-induced IFN-I
$635,946Tyler J. Curiel · Dartmouth-Hitchcock Clinic · R01 · FY2024 · CA
Melanocyte PDL1 control of UVB-induced IFN-I
$635,946Tyler J. Curiel · Dartmouth-Hitchcock Clinic · R01 · FY2025 · CA
Host Response to TB and AIDS
$635,945New York University School Of Medicine · R01 · FY2002 · HL
Ultrasmall particle-based solutions for inducing ferroptosis and improving anti-tumor immune responses in cancer
$635,854Michelle S Bradbury · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Microfluidic Assessment of Clinical Outcomes in Preterm Newborns
$635,840Lyle L Moldawer · University Of Florida · R01 · FY2021 · HD
Development Of New Chemotherapeutics For Tuberculosis
$635,835Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Biology of R-Spondin-Induced Sensitization to Asparaginase in Colorectal Cancer
$635,809Alejandro Gutierrez · St. Jude Children'S Research Hospital · R01 · FY2024 · CA
PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE BIOMARKERS; TASK ORDER: PREVENTION OF COLORECTAL CANCER WITH IPSC-
$635,712Powel Brown · University Of Tx Md Anderson Can Ctr · N01 · FY2021 · CA
Clinical translation of a PD-L1 PET tracer to optimize immune checkpoint therapy in patients with non-small cell lung cancers
$635,583Sridhar Nimmagadda · Johns Hopkins University · R01 · FY2024 · CA
Impact of mutation burden on cancer growth and the immune landscape
$635,557Shridar Ganesan · Rutgers Biomedical And Health Sciences · R01 · FY2023 · CA
Immunobiology and immunotherapy of pancreatic cancer
$635,533Robert H Vonderheide · University Of Pennsylvania · R01 · FY2015 · CA
Accelerated Brachytherapy Forward Chemoradiation Therapy (ABC-RT) for Cervical Cancer
$635,516Stephanie Subasic Markovina · Washington University · R37 · FY2025 · CA
Rational Approaches to Melanoma Therapy
$635,508Jessie Villanueva · Wistar Institute · U54 · FY2023 · CA
Lymphangiogenesis in Pulmonary Lymphangioleiomyomatosis (LAM)
$635,396Vera P Krymskaya · University Of Pennsylvania · R01 · FY2017 · HL
Anti-tumor immunity and intestinal microbiota are modulated by mitochondrial DNA
$635,296Douglas C Wallace · Children'S Hosp Of Philadelphia · R01 · FY2025 · CA
Mechanisms of lmmunosuppression in MYCN-driven Neuroblastoma
$635,173Hui Feng · Boston University Medical Campus · R01 · FY2025 · NS